ArticleJournal of radiation research2014

Neoadjuvant capecitabine, bevacizumab and radiotherapy for locally advanced rectal cancer: results of a single-institute Phase I study.

Yoshitaka Miki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.